AYTU BIOPHARMA, INC Increase (Decrease) in Other Current Assets
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Other Current Assets of -$6.07 million for the 9-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2021-05-17
- AYTU BIOPHARMA, INC increase (decrease) in other current assets for the quarter ending 2021-03-31 was -$3.77M, a 1803.78% decline year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in other current assets for the quarter ending 2020-12-31 was -$2.53M, a 1952.88% decline year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in other current assets for the quarter ending 2020-09-30 was $237.72K.
- AYTU BIOPHARMA, INC increase (decrease) in other current assets for the quarter ending 2020-06-30 was $3.39M.
- AYTU BIOPHARMA, INC increase (decrease) in other current assets for fiscal 2020 was $3.75M.
- AYTU BIOPHARMA, INC increase (decrease) in other current assets for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | -$6.30M derived: sum of 2 quarters · filed 2021-05-17 | -$6.07M 10-Q · filed 2021-05-17 | -$2.67M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-12-31 | -$2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | -$2.30M 10-Q · filed 2021-02-11 | $1.10M derived: sum of 3 quarters · filed 2021-02-11 | $1.32M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-09-30 | $237.72K 10-Q · filed 2020-11-12 | $3.63M derived: sum of 2 quarters · filed 2020-11-12 | $3.85M derived: sum of 3 quarters · filed 2021-05-17 | $3.99M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-06-30 | $3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $3.61M derived: sum of 2 quarters · filed 2021-05-17 | $3.75M derived: sum of 3 quarters · filed 2021-05-17 | $3.75M 10-K · filed 2020-10-06 |
| 2020-03-31 | $221.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $358.02K derived: sum of 2 quarters · filed 2021-05-17 | $358.02K 10-Q · filed 2021-05-17 | $358.02K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $136.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | $136.69K 10-Q · filed 2021-02-11 | $136.69K derived: sum of 3 quarters · filed 2021-02-11 | $136.69K derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 derived: sum of 3 quarters · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $0.00 derived: sum of 2 quarters · filed 2020-10-06 | $0.00 10-K · filed 2020-10-06 | |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $0.00 10-Q · filed 2020-05-15 | ||
| 2018-12-31 | $0.00 10-Q · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |